CRISPR/Cas9

被引:4
|
作者
Mizuno, Naoaki [1 ]
Mizutani, Eiji [1 ]
Sato, Hideyuki [1 ]
Kasai, Mariko [1 ]
Nakauchi, Hiromitsu [1 ,2 ]
Yamaguchi, Tomoyuki [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Minato Ku, Tokyo, Japan
[2] Stanford Univ, Sch Med, Dept Genet, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA
来源
BIO-PROTOCOL | 2019年 / 9卷 / 13期
关键词
CRISPR/Cas9; Adeno-associated viral vector; Trans-zona pellucida; Intra-embryo genome editing; Ribonucleoprotein electroporation; Large fragment knock-in; ELECTROPORATION;
D O I
10.21769/BioProtoc.3295
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intra-embryo genome editing by CRISPR/Cas9 has enabled rapid generation of gene knockout animals. However, large fragment knock-in directly into embryos' genome is still difficult, especially without microinjection of donor DNA. Viral vectors are good transporters of knock-in donor DNA for cell lines, but seemed unsuitable for pre-implantation embryos with zona pellucida, glycoprotein membrane surrounding early embryos. We found adeno-associated virus (AAV) can infect zygotes of various mammals through intact zona pellucida. AAV-mediated donor DNA delivery following Cas9 ribonucleoprotein electroporation enables large fragment knock-in without micromanipulation.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Nanoparticles for CRISPR–Cas9 delivery
    Zachary Glass
    Yamin Li
    Qiaobing Xu
    Nature Biomedical Engineering, 2017, 1 : 854 - 855
  • [22] CRISPR–Cas9 wins Nobel
    Paulina Strzyz
    Nature Reviews Molecular Cell Biology, 2020, 21 : 714 - 714
  • [23] Structure and mechanism of CRISPR/Cas9
    Taylor, David W.
    JOURNAL OF ANIMAL SCIENCE, 2019, 97 : 56 - 57
  • [24] Anything impossible with CRISPR/Cas9?
    Renjie Jiao
    Caixia Gao
    Science China Life Sciences, 2017, 60 : 445 - 446
  • [25] Putting the brakes on CRISPR–Cas9
    Vesna Todorovic
    Nature Methods, 2017, 14 : 108 - 108
  • [26] CRISPR/Cas9: Prospects and Challenges
    Zhang, Feng
    HUMAN GENE THERAPY, 2015, 26 (07) : 409 - 410
  • [27] Allergan dives into CRISPR–Cas9
    Nature Biotechnology, 2017, 35 : 296 - 296
  • [28] CRISPR screens beyond Cas9
    Burgess, Darren J.
    NATURE REVIEWS GENETICS, 2020, 21 (05) : 273 - 273
  • [29] CRISPR/Cas9 in Gastrointestinal Malignancies
    Jefremow, Andre
    Neurath, Markus F.
    Waldner, Maximilian J.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [30] The Potential of CRISPR/Cas9 in Hematotherapy
    Bak, Rasmus O.
    STEM CELLS AND DEVELOPMENT, 2019, 28 (11) : 710 - 711